Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Donghua He, Tianyan Ma, Ni Yi, Sijie Zhang & Guanxiong Ding. (2023) Significance of PBRM1 mutation in disease progress and drug selection in clear cell renal cell carcinoma. Biotechnology and Genetic Engineering Reviews 0:0, pages 1-15.
Read now
Read now
Anahita Fathi, Christine Dahlke & Marylyn M. Addo. (2019) Recombinant vesicular stomatitis virus vector vaccines for WHO blueprint priority pathogens. Human Vaccines & Immunotherapeutics 15:10, pages 2269-2285.
Read now
Read now
Articles from other publishers (21)
V. D. Moroz, N. B. Gasanov, A. D. Egorov, A. S. Malogolovkin, M. O. Nagornykh, E. N. Subcheva, E. S. Kolosova, A. Yu. Fizikova, R. A. Ivanov & A. V. Karabelsky. (2024) A Method for the Production of Recombinant VSVs with Confirmation of Biological Activity. Acta Naturae 16:1, pages 59-66.
Crossref
Crossref
RamaRao Malla, Mundla Srilatha, Batoul Farran & Ganji Purnachandra Nagaraju. (2024) mRNA vaccines and their delivery strategies: A journey from infectious diseases to cancer. Molecular Therapy 32:1, pages 13-31.
Crossref
Crossref
Anastasia Ryapolova, Ekaterina Minskaia, Nizami Gasanov, Vasiliy Moroz, Bogdan Krapivin, Alexander D. Egorov, Victor Laktyushkin, Sofia Zhuravleva, Maksim Nagornych, Elena Subcheva, Alexander Malogolovkin, Roman Ivanov & Alexander Karabelsky. (2023) Development of Recombinant Oncolytic rVSV-mIL12-mGMCSF for Cancer Immunotherapy. International Journal of Molecular Sciences 25:1, pages 211.
Crossref
Crossref
Büşra Ahata & Günseli Bayram Akçapınar. (2023) CCHFV vaccine development, current challenges, limitations, and future directions. Frontiers in Immunology 14.
Crossref
Crossref
Arash Letafati, Omid Salahi Ardekani, Mina Naderisemiromi, Mohammad Mehdi Fazeli, Nillofar Asadi Jemezghani & Jila Yavarian. (2023) Oncolytic viruses against cancer, promising or delusion?. Medical Oncology 40:8.
Crossref
Crossref
Bolni Marius Nagalo, Yumei Zhou, Emilien J. Loeuillard, Chelsae Dumbauld, Oumar Barro, Natalie M. Elliott, Alexander T. Baker, Mansi Arora, James M. Bogenberger, Nathalie Meurice, Joachim Petit, Pedro Luiz Serrano Uson, Faaiq Aslam, Elizabeth Raupach, Musa Gabere, Alexei Basnakian, Camila C. Simoes, Martin J. Cannon, Steven R. Post, Kenneth Buetow, Jean Christopher Chamcheu, Michael T. Barrett, Dan G. Duda, Bertram Jacobs, Richard Vile, Michael A. Barry, Lewis R. Roberts, Sumera Ilyas & Mitesh J. Borad. (2023) Characterization of Morreton virus as an oncolytic virotherapy platform for liver cancers. Hepatology 77:6, pages 1943-1957.
Crossref
Crossref
Cordin ArpagausCordin Arpagaus. 2023. Spray Drying of Vaccines. Spray Drying of Vaccines
325
530
.
Zrinka Matić & Maja Šantak. (2021) Current view on novel vaccine technologies to combat human infectious diseases. Applied Microbiology and Biotechnology 106:1, pages 25-56.
Crossref
Crossref
Niloufar Tavakoli Dastjerd, Ali Valibeik, Sobhan Rahimi Monfared, Golnaz Goodarzi, Mostafa Moradi Sarabi, Faezeh Hajabdollahi, Mahmood Maniati, Jamal Amri & Sadra Samavarchi Tehrani. (2021) Gene therapy: A promising approach for breast cancer treatment. Cell Biochemistry and Function 40:1, pages 28-48.
Crossref
Crossref
Johannes P. W. Heidbuechel & Christine E. Engeland. (2021) Oncolytic viruses encoding bispecific T cell engagers: a blueprint for emerging immunovirotherapies. Journal of Hematology & Oncology 14:1.
Crossref
Crossref
Arik Makovitzki, Elad Lerer, Yaron Kafri, Yaakov Adar, Lilach Cherry, Edith Lupu, Arik Monash, Rona Levy, Ofir Israeli, Eyal Dor, Eyal Epstein, Lilach Levin, Einat Toister, Idan Hefetz, Ophir Hazan, Irit Simon, Arnon Tal, Meni Girshengorn, Hanan Tzadok, Osnat Rosen & Ziv Oren. (2021) Evaluation of a downstream process for the recovery and concentration of a Cell-Culture-Derived rVSV-Spike COVID-19 vaccine candidate. Vaccine 39:48, pages 7044-7051.
Crossref
Crossref
Alexander Malogolovkin, Nizami Gasanov, Alexander Egorov, Marianna Weener, Roman Ivanov & Alexander Karabelsky. (2021) Combinatorial Approaches for Cancer Treatment Using Oncolytic Viruses: Projecting the Perspectives through Clinical Trials Outcomes. Viruses 13:7, pages 1271.
Crossref
Crossref
Alexandru A. Hennrich, Bevan Sawatsky, Rosalía Santos-Mandujano, Dominic H. Banda, Martina Oberhuber, Anika Schopf, Verena Pfaffinger, Kevin Wittwer, Christiane Riedel, Christian K. Pfaller & Karl-Klaus Conzelmann. (2021) Safe and effective two-in-one replicon-and-VLP minispike vaccine for COVID-19: Protection of mice after a single immunization. PLOS Pathogens 17:4, pages e1009064.
Crossref
Crossref
E. Heilmann, J. Kimpel, B. Hofer, A. Rössler, I. Blaas, L. Egerer, T. Nolden, C. Urbiola, H. G. Kräusslich, G. Wollmann & D. von Laer. (2021) Chemogenetic ON and OFF switches for RNA virus replication. Nature Communications 12:1.
Crossref
Crossref
Elodie Belnoue, Alyssa A. Leystra, Susanna Carboni, Harry S. Cooper, Rodrigo T. Macedo, Kristen N. Harvey, Kimberly B. Colby, Kerry S. Campbell, Lisa A. Vanderveer, Margie L. Clapper & Madiha Derouazi. (2021) Novel Protein-Based Vaccine against Self-Antigen Reduces the Formation of Sporadic Colon Adenomas in Mice. Cancers 13:4, pages 845.
Crossref
Crossref
Emanuele Sasso, Anna Morena D’Alise, Nicola Zambrano, Elisa Scarselli, Antonella Folgori & Alfredo Nicosia. (2020) New viral vectors for infectious diseases and cancer. Seminars in Immunology 50, pages 101430.
Crossref
Crossref
Rui Li, Songlin Qiao, Xin-xin Chen, Guangxu Xing, Xuewu Li & Gaiping Zhang. (2020) Vesicular stomatitis virus glycoprotein suppresses nuclear factor kappa-B- and mitogen-activated protein kinase-mediated pro-inflammatory responses dependent on sialic acids. International Journal of Biological Macromolecules 152, pages 828-833.
Crossref
Crossref
Tao Shi, Xueru Song, Yue Wang, Fangcen Liu & Jia Wei. (2020) Combining Oncolytic Viruses With Cancer Immunotherapy: Establishing a New Generation of Cancer Treatment. Frontiers in Immunology 11.
Crossref
Crossref
Jean-François Gélinas, Sascha Kiesslich, Rénald Gilbert & Amine A. Kamen. (2020) Titration methods for rVSV-based vaccine manufacturing. MethodsX 7, pages 100806.
Crossref
Crossref
Lisa Pipperger, Iris Koske, Nicole Wild, Brigitte Müllauer, Daniela Krenn, Heribert Stoiber, Guido Wollmann, Janine Kimpel, Dorothee von Laer & Zoltán Bánki. (2019) Xenoantigen-Dependent Complement-Mediated Neutralization of Lymphocytic Choriomeningitis Virus Glycoprotein-Pseudotyped Vesicular Stomatitis Virus in Human Serum. Journal of Virology 93:18.
Crossref
Crossref
C. Bresk, Tamara Hofer, Sarah Wilmschen, Marina Krismer, Anja Beierfuß, Grégory Effantin, Winfried Weissenhorn, Michael Hogan, Andrea Jordan, Rebecca Gelman, David Montefiori, Hua-Xin Liao, Joern Schmitz, Barton Haynes, Dorothee von Laer & Janine Kimpel. (2019) Induction of Tier 1 HIV Neutralizing Antibodies by Envelope Trimers Incorporated into a Replication Competent Vesicular Stomatitis Virus Vector. Viruses 11:2, pages 159.
Crossref
Crossref